Plby Group Inc
Change company Symbol lookup
Select an option...
PLBY Plby Group Inc
SVFA SVF Investment Corp
ROIUF Route1 Inc
MPB Mid Penn Bancorp Inc
NWSA News Corp
BAC Bank of America Corp
BA Boeing Co
EGRNF China Evergrande Group
SHYF Shyft Group Inc
NGS Natural Gas Services Group Inc

Consumer Discretionary : Textiles, Apparel & Luxury Goods | Small Cap Growth
Company profile

PLBY Group, Inc., formerly Mountain Crest Acquisition Corp, is a leisure lifestyle company and owner of Playboy brand. The Company is principally engaged in connecting consumers around the world with products, services, and experiences. It has three reportable segments: Licensing, which includes licensing of Playboy brands to third parties; Direct-to-Consumer, including sales of third-party products through its owned-and-operated ecommerce platforms; and Digital Subscriptions and Content, including the sale of subscriptions to Playboy programming and trademark licensing for online gaming products. The Company's products are classified under four market categories: Sexual Wellness, including intimacy products and lingerie; Style and Apparel, including a variety of apparel and accessories products for men and women; Gaming and Lifestyle, such as digital gaming, hospitality and spirits; and, Beauty and Grooming, including fragrance, skincare, grooming and cosmetics for women and men.

Closing Price
Day's Change
0.06 (0.26%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Pfizer booster likely to be OK'd by Sept. 20, but Moderna's may lag, Fauci says

8:17 am ET September 7, 2021 (MarketWatch)

By Mike Murphy

Fauci says delay in approving Moderna's shot shouldn't be long

The Pfizer-BioNTech shot will likely be the only COVID-19 vaccine booster available by Sept. 20, the Biden administration's target date to begin offering them, but Dr. Anthony Fauci said Sunday that Moderna's shot shouldn't be too far behind.

Speaking Sunday on CBS News' "Face the Nation," Fauci, the White House's top pandemic adviser, said Moderna's (MRNA) booster might not have approval from the Food and Drug Administration by that date.

"We were hoping that we would get both the candidates, both products, Moderna and Pfizer, rolled out by the week of the 20th. It is conceivable that we will only have one of them out, but the other would likely follow soon thereafter," Fauci told host Weijia Jiang.

Boosters for the general public have not won FDA approval yet, though the one from Pfizer (PFE) and BioNTech (BNTX) appears to be on track. "Looks like Pfizer has their data in, likely would meet the deadline," Fauci said. "We hope that Moderna would also be able to do it, so we could do it simultaneously."

"But if not, we'll do it sequentially," he added. "So the bottom line is, very likely, at least part of the plan will be implemented, but ultimately the entire plan will be." Fauci said any delay in approving Moderna's shot would likely be "at most a couple of weeks."

Read:COVID-19 vaccine booster shots are more complicated than they appear. Here's why

Officials have said those who got the Johnson & Johnson (JNJ) vaccine will also likely need a booster, but no other details have been announced.

For now, Fauci said, fully vaccinated people should plan on getting a booster of whichever shot they were originally given. He said data on whether Americans could mix vaccines -- getting a Pfizer booster after getting the original two-dose Moderna shots, for example -- is currently being studied, and should be released to the public in the coming weeks.

The Biden administration has pushed for a Sept. 20 start date for fully vaccinated people to begin getting boosters, as long as it's been at least eight months since they were vaccinated. Federal officials are worried that the effectiveness of the vaccines may decrease over time, and are looking to boosters to prevent another winter surge in new cases. The first round of boosters will go to people most at risk of the coronavirus.

-Mike Murphy


(END) Dow Jones Newswires

September 07, 2021 08:17 ET (12:17 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.